Short answer
GLAUKOS Corp (GKOS) filed its Q1 2026 10-Q quarterly report on Apr 30, 2026 for the quarter ended Mar 31, 2026. Quarterly revenue was $151M (up 41.2% year over year) with net income of −$20M.
Q1 2026 key financials · XBRL
- Revenue
- $151M
- +41.2% YoY
- Net income
- −$20M
- −9.0% YoY
- Operating margin
- -13.2%
- Gross margin
- 77.9%
- EPS (diluted)
- −$0.34
- −6.3% YoY
Source: XBRL data from the GLAUKOS Corp (GKOS) Q1 2026 10-Q on SEC EDGAR. USD.
GLAUKOS Corp Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No new risk factors provided; excerpt contains MD&A rather than the 10-Q Risk Factors section
- Regulatory exposure: MDRP participation increased accrued rebates on Photrexa U.S. sales by $2.1 million
- Operational risk: low production volumes leave significant per-unit costs allocated to manufacturing overhead
- Financial risk: operating activities consumed $12.5 million in cash during the quarter
- Capital commitment risk: Huntsville facility anticipated to require more than $80.0 million over multiple years
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other GLAUKOS Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.